Managed Care
Disease
Management

Peer-Reviewed Articles from Managed Care

Research Articles from Managed Care

Fung Lam, MD ; Niki B. Istwan, RN, BS ; Debbie Jacques, MPH ; Suzanne K. Coleman, RNC, MS ; Gary J. Stanziano, MD
Continuous subcutaneous terbutaline infusion shows improved clinical outcomes and decreased nursery costs compared with oral tocolytics in women with recurrent preterm labor.
William Silverman, MD, FAAP
The appropriate application of criteria for the use of palivizumab can save health plans a significant amount of money.
David M. Pariser, MD
The impact of this debilitating disease has been largely underestimated, yet new biologic agents offer significant clinical benefit to those afflicted.
Julian Casciano ; Karine Amaya, PhD ; John Doyle, MPH ; Steve Arikian, MD ; Neil Shear, MD
Thomas Kaye, RPh, MBA
Assuring the safety and efficacy of pharmaceuticals is important to any managed care organization. Compounding in the pharmacy needs scrutiny.
Steven Andes, PhD, CPA ; Lawrence M. Metzger, PhD, CPA ; John Kralewski, PhD ; David Gans, MSHA
J. Stephen Jones, MD ; Niki B. Istwan, RN ; Debbie Jacques, MPH ; Suzanne K. Coleman, MSc ; Gary Stanziano, MD
Robert I. Garis, RPh, PhD ; Kevin C. Farmer, PhD
Gregory D. Berg, PhD ; Sandeep Wadhwa, MD, MBA
Ernest P. Schloss, PhD ; Vicky Lewis, RN, PhD ; Nancy Martin, RN, MSN ; Marlene Pitts, BSN, RN

Pages

Meetings

HealthIMPACT Southeast Tampa, FL January 23, 2015